Biofrontera's market cap is currently $9.85M. The company's EPS TTM is $-2.265; its P/E ratio is ―; Biofrontera is scheduled to report earnings on April 4, 2025, and the estimated EPS forecast is $-0.03. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 34.07M	$ 28.67M	$ 24.10M	$ 18.85M	$ 26.18M
Gross Profit	$ 16.63M	$ 13.49M	$ 11.36M	$ 9.78M	$ 13.77M
Operating Income	$ -22.68M	$ -22.38M	$ -25.85M	$ -8.33M	$ -14.92M
EBITDA	$ -18.45M	$ 934.00K	$ -36.76M	$ -7.49M	$ -8.15M
Net Income	$ -20.13M	$ -640.00K	$ -37.71M	$ -10.99M	$ -10.98M
Balance Sheet
Cash & Short-Term Investments	$ 1.42M	$ 27.76M	$ 24.55M	$ 8.08M	$ 7.30M
Total Assets	$ 27.93M	$ 50.88M	$ 53.22M	$ 24.14M	$ 28.75M
Total Debt	$ 5.40M	$ 1.35M	$ 0.00	$ 0.00	$ 38.20M
Net Debt	$ 4.06M	$ -15.86M	$ -24.55M	$ -8.08M	$ 30.90M
Total Liabilities	$ 23.14M	$ 27.00M	$ 41.88M	$ 18.31M	$ 58.93M
Stockholders' Equity	$ 4.79M	$ 23.88M	$ 11.34M	$ 5.83M	$ -30.18M
Cash Flow
Free Cash Flow	$ -24.90M	$ -16.24M	$ -26.73M	$ -12.37M	$ -38.22M
Operating Cash Flow	$ -24.89M	$ -16.20M	$ -26.71M	$ -12.37M	$ -37.68M
Investing Cash Flow	$ 619.00K	$ -5.16M	$ -11.00K	$ 0.00	$ 25.39M
Financing Cash Flow	$ 8.41M	$ 14.02M	$ 43.19M	$ 13.19M	$ 16.40M

Currency in USD

Biofrontera Earnings and Revenue History

Income Statement >

Biofrontera Debt to Assets

Balance Sheet >

Biofrontera Cash Flow

Cash Flow >

Biofrontera Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing